NEURONETICS

Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment.

#SimilarOrganizations #People #Financial #Website #More

NEURONETICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Medical Device Therapeutics

Founded:

2003-01-01

Address:

Malvern, Pennsylvania, United States

Country:

United States

Website Url:

http://www.neurostar.com

Total Employee:

101+

Status:

Active

Contact:

877-600-7555

Email Addresses:

[email protected]

Total Funding:

313.4 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome

Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

agenus-logo

Agenus

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

cadent-therapeutics-logo

Cadent Therapeutics

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

photometics-logo

Photometics

Photometics develops infrared light-based therapy for skin cancer.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Advisors List

bruce-shook_image

Bruce Shook Director, Chair Nominating & Corporate Governance Committee @ Neuronetics
Board_member
2020-07-01

brian-farley_image

Brian Farley Board Member @ Neuronetics
Board_member
2016-01-01

stephen-campe_image

Stephen Campe Board Member @ Neuronetics
Board_member
2013-01-01

glenn-muir_image

Glenn Muir Board Member @ Neuronetics
Board_member
2017-08-01

wilfred-jaeger_image

Wilfred Jaeger Board Member @ Neuronetics
Board_member
2005-03-01

chris-thatcher_image

Chris Thatcher Board Member @ Neuronetics
Board_member

Current Employees Featured

charles-e-larsen_image

Charles E. Larsen
Charles E. Larsen Co-Founder @ Neuronetics
Co-Founder

steve-mackinnon_image

Steve MacKinnon
Steve MacKinnon Vice President of Sales @ Neuronetics
Vice President of Sales

judy-p-ways_image

Judy P. Ways
Judy P. Ways Vice President, Regulatory Affairs and Quality Assurance @ Neuronetics
Vice President, Regulatory Affairs and Quality Assurance
2003-04-01

cory-anderson_image